Skip to content

Effects of Implementation of a new Pain, Agitation, and Delirium guideline in the Intensive Care Unit.

Prevention of Delirium in the Intensive Care Unit (ICU)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON23254
Enrollment
100
Registered
2014-11-13
Start date
2014-11-17
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of critically ill patients in the ICU is often complicated by the onset of delirium. Delirium is a psycho-organic disorder , characterized by an acute disturbance of consciousness and changes in cognition, often with a fluctuating course. Symptoms of delirium include change in level of awareness, decreased attention span, memory deficit, disorientation, language disturbance and hallucinations. Other symptoms commonly associated with delirium are confusion, agitation, apathy, anxiety,

Interventions

All ICU patients included in the study will be treated according to the new pain, agitation, and delirium guideline during 12 weeks (group A). Primary and secondary outcomes will be registered. Data w

Sponsors

Atrium Medisch Centrum Parkstad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients admitted to the Intensive Care Unit of the Atrium Medisch Centrum Parkstad between November 2014 and February 2015 are treated according to latest Pain, Agitation, and Delirium guideline.

Exclusion criteria

Exclusion criteria: -Age < 18 years -Pre-existent delirium 24 hours before admittance to ICU -Richmond Agitation Sedation Score (RASS) -4/-5 during ICU stay -< 24 hours ICU stay -Deafness or serious visual impairment -Unable to speak or understand Dutch language -Serious mental handicaps -Pre-existent cognitive impairment or dementia -Aphasia -Delirium screening compliance rate <80% during ICU stay

Design outcomes

Primary

MeasureTime frame
Delirium incidence

Secondary

MeasureTime frame
ICU stay, hospital stay, mortality, comorbidity, NRS/CPOT score, RASS score, CAM-ICU score.

Contacts

Public ContactH.J.H. Bremer

Psychiater Atrium Medisch Centrum Parkstad Henri Dunantstraat 5

h.bremer@atriummc.nl045-5766490

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)